Chinese Journal of Clinical Pharmacology and Therapeutics ›› 2010, Vol. 15 ›› Issue (10): 1174-1182.
Previous Articles Next Articles
CHEN Jiang-fei, XU Ping, ZHU Su-yan, HU Yi-jian
Received:
2010-08-07
Revised:
2010-10-15
Published:
2020-09-16
CLC Number:
CHEN Jiang-fei, XU Ping, ZHU Su-yan, HU Yi-jian. Advance in research for pharmacokinetics and drug interactions of licorice[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2010, 15(10): 1174-1182.
Add to citation manager EndNote|Ris|BibTeX
URL: https://manu41.magtech.com.cn/Jweb_clyl/EN/
https://manu41.magtech.com.cn/Jweb_clyl/EN/Y2010/V15/I10/1174
[1] Afreen F,Zobayed SMA,Kozai T.Spectral quality and UV-B stress stimulate glycyrrhizin concentration of Glycyrrhiza uralensis in hydroponic and pot system[J].Plant Physiol Biochem,2005,43(12):1074-1081. [2] 田代华.实用中药辞典(上卷)[M].北京:人民卫生出版社,2002:428-429. [3] 朱绪民,邸迎彤,彭树林,等.乌拉尔甘草中的化学成分[J].中草药,2003,34(3):199-201. [4] Li JR,Wang YQ,Deng ZZ.Two new compounds from glycyrrhiza glabra[J].J Asian Nat Prod Res,2005,7(4):677-680. [5] 吴汉夔,赵芸,牟新利,等.新疆甘草化学成分研究[J].天然产物研究与开发,2006,18(3):415-417. [6] Kinoshita T,Tamura Y,Mizutani K.The isolation and structure elucidation of minor isoflavonoids from licorice of glycyrrhiza glabra origin[J].Chem Pharm Bull,2005,53(7):847-849. [7] Hatano T,Aga Y,Shintani Y,et al.Minor flavonoids from licorice[J].Phytochemistry,2000,55(8):959-963. [8] 白虹,窦德强,裴玉萍,等.栽培甘草的化学成分研究[J].中草药,2005,36(5):652-654. [9] Cantelli-Forti G,Maffei F,Hrelia P,et al.Interaction of licorice on glycyrrhizin pharmacokinetics[J].Environ Health Perspect,1994,102(9):65-68. [10] Wang Z,Kurosaki Y,Nakayama T,et al.Mechanism of gastrointestinal absorption of glycyrrhizin in rats[J].Biol Pharm Bull,1994,17(10):1399-1403. [11] Yamamura Y,Santa T,Kotaki H,et al.Administration-route dependency of absorption of glycyrrhizin in rats: intraperitoneal administration dramatically enhanced bioavailability[J].Biol Pharm Bull,1995,18(2):337-341. [12] Gunnarsdottir S,Johannesson T.Glycyrrhetic acid in human blood after ingestion of glycyrrhizic acid in licorice[J].Pharmacol Toxicol,1997,81(6):300-302. [13] Takeda S,Ishihara K,Wakui Y,et al.Bioavailability study of glycyrrhetic acid after oral administration of glycyrrhizin in rats; relevance to the intestinal bacterial hydrolysis[J].J Pharm Pharmacol,1996,48(9):902-905. [14] Gunnarsdottir S,Johannesson T.Glycyrrhetic acid in human blood after ingestion of glycyrrhizic acid in licorice[J].Pharmacol Toxicol,1997,81(6):300-302. [15] Hou YC,Hsiu SL,Ching H,et al.Profound difference of metabolic pharmacokinetics between pure glycyrrhizin and glycyrrhizin in licorice decoction[J].Life Sci,2005,76(10):1167-1176. [16] Wang Z,Nishioka M,Kurosaki Y,et al.Gastrointestinal absorption characteristics of glycyrrhizin from glycyrrhiza extract[J].Biol Pharm Bull,1995,18(9):1238-1241. [17] Cantelli-Forti G,Raggi MA,Bugamelli F,et al.Toxicological assessment of liquorice: biliary excretion in rats[J].Pharmacol Res,1997,35(5):463-470. [18] 任平,黄熙,张莉,等.脾虚证大鼠甘草甜素药物动力学特征与胃肠动力的关系研究[J].安徽中医学院学报,2000,19(4):47-50. [19] 任平,黄熙,张莉,等.不同脾虚时期大鼠甘草甜素药物动力学特征及其机制的探讨[J].成都中医药大学学报,2000,23(2):30-32. [20] Akao T.Localization of enzymes involved in metabolism of glycyrrhizin in contents of rat gastrointestinal tract[J].Biol Pharm Bull,1997,20(2):122-126. [21] Akao T.Hydrolysis of glycyrrhetyl mono-glucuronide to glycyrrhetic acid by glycyrrhetyl mono-glucuronide β-D-glucuronidase of Eubacterium sp. GLH[J].Biol Pharm Bull,1997,20(12):1245-1249. [22] Kim DH,Lee SW,Han MJ.Biotransformation of glycyrrhizin to 18β-glycyrrhetinic acid-3-O-β-D -glucuronide by Streptococcus LJ-22, a human intestinal bacterium[J].Biol Pharm Bull,1999,22(3):320-322. [23] Kim DH,Hong SW,Kim BT,et al.Biotransformation of glycyrrhizin by human intestinal bacteria and its relation to biological activities[J].Arch Pharm Res,2000,23(2):172-173. [24] Kato H,Kanaoka M,Yano S,et al.3-Monoglucuronyl-glycyrrhetinic acids is a major metabolite that causes licorice-induced pseudoaldosteronism[J]. J Clin Endocrinol Metab,1995,80(6):1929-1933. [25] Mizuhara Y,Takizawa Y,Ishihara K,et al.The influence of the sennosides on absorption of glycyrrhetic acid in rats[J].Biol Pharm Bull,2005,28(10):1897-1902. [26] Ching H,Hou YC,Hsiu SL,et al.Influence of honey on the gastrointestinal metabolism and disposition of glycyrrhizin and glycyrrhetic acid in rabbits[J].Biol Pharm Bull,2002,25(1):87-91. [27] Ishida S,Ichikawa T,Sakiya Y.Binding of glycyrrhetinic acid to rat plasma, rat serum albumin, human serum, and human serum albumin[J].Chem Pharm Bull,1988,36(1):440-443. [28] Ishida S,Sakiya Y,Ichikawa T,et al.Binding of glycyrrhizin to human serum and human serum albumin[J].Chem Pharm Bull,1989,37(1):226-228. [29] Koga K,Tomoyama M,Ohyanagi K,et al.Pharmacokinetics of glycyrrhizin in normal and albumin-deficient rats[J].Biopharm Drug Dispos,2008,29(7):373-381. [30] Ishida S,Sakiya Y,Ichikawa T,et al.Pharmacokinetics of glycyrrhetic acid, a major metabolite of glycyrrhizin, in rats[J].Chem Pharm Bull,1989,37(9):2509-2413. [31] Ichikawa T,Ishida S,Sakiya Y,et al.High-performance liquid chromatographic determination of glycyrrhizin and glycyrrhetinic acid in biological materials[J].Chem Pharm Bull,1984,32(9):3734-3738. [32] 范益,丁建花,刘苏怡,等.α-与β-甘草酸在小鼠体内分布的研究[J].中国临床药理学与治疗学,2004,9(6):619-622. [33] Hundertmark S,Dill A,Buhler H,et al.11β-Hydroxysteroid dehydrogenase type 1: a new regulator of fetal lung maturation[J].Horm Metab Res,2002,34(10):537-544. [34] Ishida S,Sakiya Y,Ichikawa T,et al.Dose-dependent pharmacokinetics of glycyrrhizin in rats[J].Chem Pharm Bull,1992,40(7):1917-1920. [35] Ishida S,Sakiya Y,Ichikawa T,et al.Uptake of glycyrrhizin by isolated rat hepatocytes[J].Biol Pharm Bull,1993,16(3):293-297. [36] Ishida S,Sakiya Y,Taira Z.Disposition of glycyrrhizin in the perfused liver of rats[J].Biol Pharm Bull,1994,17(7):960-969. [37] Kawakami J,Yamamura Y,Santa T,et al.Kinetic analysis of glycyrrhetic acid, an active metabolite of glycyrrhizin, in rats: role of enterohepatic circulation[J].J Pharm Sci,1993,82(3):301-305. [38] Iveson P,Lindup WE,Parke DV,et al.The metabolism of carbenoxolone in the rat[J].Xenobiotica,1971,1(1):79-95. [39] Akao T,Aoyama M,Akao T,et al.Metabolism of glycyrrhetic acid by rat liver microsomes Ⅱ 22α- and 24-hydroxylation[J].Biochem Pharmacol,1990,40(2):291-296. [40] 高凯,余伟,杨静,等.大鼠肝微粒体CYP3A1/2和CYP2C9/10参与甘草次酸的羟化代谢[J].中国临床药理学与治疗学,2007,12(11):1255-1260. [41] Akao T,Akao T,Kobashi K.Metabolism of glycyrrhetic acid by rat liver microsomes: glycyrrhetinate dehydrogenase[J].Biochim Biophys Acta,1990,1042(2):241-246. [42] Akao T,Akao T,Aoyama M,et al.Metabolism of glycyrrhetic acid by rat liver microsomes-Ⅲ. Male-specific glycyrrhetinate dehydrogenase[J].Biochem Pharmacol,1991,42(1):103-107. [43] Jing J,Ren W,Chen X,et al.Glucuronide-sulfate diconjugate as a novel metabolite of glycyrrhetic acid in rat bile[J].Drug Metab Pharmacokinet,2008,23(3):175-180. [44] Yamamura Y,Kawakami J,Santa T,et al.Pharmacokinetic profile of glycyrrhizin in healthy volunteers by a new high-performance liquid chromatographic method[J].J Pharma Sci,1992,81(10):1042-1046. [45] van Rossum TG,Vulto AG,Hop WC,et al.Pharmacokinetics of intravenous glycyrrhizin after single and multiple doses in patients with chronic hepatitis C infection[J].Clin Ther,1999,21(12):2080-2090. [46] Yamamura Y,Tanaka N,Santa T,et al.The relationship between pharmacokinetic behaviour of glycyrrhizin and hepatic function in patients with acute hepatitis and liver cirrhosis[J].Biopharm Drug Dispos,1995,16(1):13-21. [47] Krahenbuhl S,Hasler F,Frey BM,et al.Kinetics and dynamics of orally administered 18β-glycyrrhetinic acid in humans[J].J Clin Endocrinol Metab,1994,78(3):581-585. [48] Ploeger B,Mensinga T,Sips A,et al.A human physiologically-based model for glycyrrhzic acid, a compound subject to presystemic metabolism and enterohepatic cycling[J].Pharm Res,2000,17(12):1516-1525. [49] Kamei J,Saitoh A,Asano T,et al.Pharmacokinetic and pharmacodynamic profiles of the antitussive principles of glycyrrhizae radix(licorice), a main component of the Kampo preparation Bakumondo-to(Mai-men-dong-tang)[J].Eur J Pharmacol,2005,507(1/3):163-168. [50] Aoki F,Nakagawa K,Kitano M,et al.Clinical safety of licorice flavonoid oil(LFO) and pharmacokinetics of glabridin in healthy humans[J].J American College of Nutrition,2007,26(3):209-218. [51] Paolini M,Pozzetti L,Sapone A,et al.Effect of licorice and glycyrrhizin on murine liver CYP-dependent monooxygenases[J].Life Sci,1998,62(6):571-582. [52] Paolini M,Barillari J,Broccoli M,et al.Effect of liquorice and glycyrrhizin on rat liver carcinogen metabolizing enzymes[J].Cancer Lett,1999,145(1/2):35-42. [53] Hu WY,Li YW,Hou YN,et al.The induction of liver microsomal cytochrome P450 by glycyrrhiza uralensis and glycyrrhetinic acid in mice[J].Biomed Environ Sci,1999,12(1):10-14. [54] 张锦楠,李亚伟,徐艳霞,等.甘草和五味子对大鼠肝微粒体CYP450诱导作用的研究[J].中国药学杂志,2002,37(6):424-426. [55] 徐艳霞,张锦楠,闫淑莲.甘草和五味子对大鼠丙咪嗪药代动力学的影响[J].首都医科大学学报,2003,24(2):121-123. [56] Tang J,Song X,Zhu M,et al.Study on the pharmacokinetics drug-drug interaction potential of glycyrrhiza uralensis, a traditional Chinese medicine, with lidocaine in rats[J].Phytother Res,2009,23(5):603-607. [57] Mu Y,Zhang JN,Zhang SM,et al.Traditional Chinese medicines Wu Wei Zi(Schisandra chinensis Bail) and Gan Cao(Glycyrrhiza uralensis Fisch) activate pregnane X receptor and increase warfarin clearance in rats[J].J Pharmacol Exp Ther,2006,316(3):1369-1377. [58] 贺平,吴孟超,李琳芳,等.甘草酸对小鼠安替比林及醋氨酚代谢的影响[J].中国药理学通报,1998,14(6):516-519. [59] 徐君辉,李士敏.甘草提取液与甘草酸对小鼠安替比林代谢影响的比较[J].中成药,2007,29(11):1673-1675. [60] Tu JH,Hu DL,Dai LL,et al.Effect of glycyrrhizin on CYP2C19 and CYP3A4 activity in healthy volunteers with different CYP2C19 genotypes[J].Xenobiotica,2010,40(6):393-399. [61] Budzinski JW,Foster BC,Vandenhoek S,et al.An in vitro evaluation of human cytochrome P450 3A4 inhibition by selected commercial herbal extracts and tinctures [J].2000,Phytomedicine,7(4):273-282. [62] Kent UM,Aviram M,Rosenbalt M,et al.The licorice root derived isoflavin glabridin inhibits the activities of human cytochrome P450S 3A4, 2B6 and 2C9 [J].Drug Metab Dispos,2002,30(6):709-715. [63] Tsukamoto S,Aburatani M,Yoshida T,et al.CYP3A4 inhibitors isolated from licorice [J].Biol Pharm Bull,2005,28(10):2000-2002. [64] 王宇光,杨明今,马增春,等.18β-甘草酸和18α-甘草酸对大鼠原代肝细胞CYP3A酶表达的影响[J].中国中药杂志,2009,34(3):307-311. [65] 杨静,彭仁琇,孔锐,等.18α-甘草酸二铵对大鼠肝脏细胞色素P450和Ⅱ相酶的影响[J].药学学报,2001,36(5):321-324. [66] 陈洁,彭仁琇.18α-甘草酸二铵对格列本脲在实验性糖尿病大鼠体内药动学的影响[J].中国药学杂志,2006,41(10):774-776. [67] Chen MF,Shimada F,Kato H,et al.Effect of oral administration of glycyrrhizin on the pharmacokinetics of prednisolone[Abstract].Endocrinol Jpn,1991,38(2):167-174. [68] Homma M,Oka K,Ikeshima K,et al.Different effects of traditional Chinese medicines containing similar herbal constituents on prednisolone pharmacokinetics[J].J Pharm Pharmacol,1995,47(8):687-692. [69] Chen L,Yang J,Davey AK,et al.Effects of diammonium glycyrrhizinate on the pharmacokinetics of aconitine in rats and the potential mechanism[J].Xenobiotica,2009,39(12):955-963. [70] Lin SP,Tsai SY,Hou YC,et al.Glycyrrhizin and licorice significantly affect the pharmacokinetics of methotrexate in rats[J].J Agric Food Chem,2009,57(5):1854-1859. [71] 程建峰,滕树保,陈东鸿,等.甘草酸和苯巴比妥钠对小鼠肝P450 3A酶的影响[J].第四军医大学学报,2000,21(8):968-970. |
[1] | WU Yujie, ZHAO Chengcheng, XI Qing. Evaluation of tegacycline regimens in treatment of gram-negative bacterial infections with Monte Carlo simulation [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(9): 1027-1033. |
[2] | LI Kun, LI Lulu, LI Nannan, HU Weihong, ZHOU Jianchao. Effects of glycaemic control and CYP3A5 polymorphisms on tacrolimus trough concentrations after adult kidney transplantation [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(7): 767-774. |
[3] | HE Xueru, LI Ying, MA Yinling, FU Yuhao, XUN Xuejiao, DONG Zhanjun. Pharmacokinetic interaction study between sorafenib and dapagliflozin in rats [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(5): 498-507. |
[4] | HUANG Zhiwei, LI Yi, XU Xiaoyong, ZHANG Lei, SHEN Yifeng, LI Huafang. Comparison of calculation results of five population pharmacokinetic analysis tools [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(5): 525-535. |
[5] | LI Mengxue, HE Jie, YU Xiaxia, HU Linlin, SHAO Hua. Research progress in population pharmacokinetics of rituximab [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(4): 468-474. |
[6] | YAN Qiangyong, XIANG Daxiong, ZHU Ronghua, YANG Lingfeng, YANG Xiding, LI Jingjing, FAN Xiao, LIU Sai, XIONG Shoujun, FANG Pingfei. Bioequivalence study of cinacalcet hydrochloride tablets in healthy Chinese volunteers [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(2): 171-177. |
[7] | LIU Lu, SHI Yufei, HE Qingfeng, XU Fengyan, WANG Kun, CAI Weimin, XIANG Xiaoqiang. Application of population modeling analysis to evaluate the impact of gene polymorphism on drug PK/PD [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(11): 1275-1282. |
[8] | ZHOU Jiating, ZHANG Xuan, XIE Zilan, LI Zhi. Interactions and clinical significance of gut microbiota and levothyroxine [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(11): 1307-1314. |
[9] | LI Xuejing, JIANG Jinping, LI Sining, WAN Linfei, ZHOU Xiangxiang, YANG Lian, LAN Ke. A bioequivalence study of generic and brand clozapine in schizophrenic patients [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(10): 1121-1130. |
[10] | WU Lili, LIANG Zhi, HUANG Siyong, WANG Yan. Effect of augmented renal clearance (ARC) on the pharmacokinetics, efficacy, and safety of vancomycin in patients with infective endocarditis [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(10): 1139-1145. |
[11] | MA Shen, LIU Yushuo, TANG Hui, CHEN Wenbin, GAO Ling. Pharmacokinetics and clinical significance of drugs for improving nonalcoholic fatty liver disease [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(8): 908-918. |
[12] | HE Xueru, FU Yuhao, XUN Xuejiao, CUI Yanjun, DONG Zhanjun. Advances in uridine diphosphate glucuronosyltransferase-mediated drug interactions with tyrosine kinase inhibitors [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(8): 936-945. |
[13] | DAI Jingyi, WANG Jingjing, ZHANG Jing, YU Jicheng, LI Nanyang, HUANG Zhiwei. Clinical application and research progress of inhaled methoxyflurane [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(7): 808-813. |
[14] | PAN Shu, WU Yijin, ZHANG Sasa, WANG Qihai, LUO Tingting, YIN Qin. Pharmacokinetics of methotrexate mediated by organic anion transporter 3 in adjuvant induced arthritis rats [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(5): 516-525. |
[15] | WU Juan, WANG Zhiqiang, ZHOU Renpeng, YANG Jingjing, QIN Huiling, ZHANG Qian, LU Chao, HU Wei. Bioequivalence trial of fasting oral sorafenib tosylate tablets in healthy Chinese subjects [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(3): 281-286. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||